Noor Ul Ain Rehman
Sat, January 10, 2026 astatine 1:57 PM CST 2 min read
Amarin Corporation plc (NASDAQ:AMRN) believes it is connected way for sustainable affirmative yearly currency travel successful 2026, supported by a afloat twelvemonth of outgo savings from its restructuring plan, the bulk of expenses related to the program already incurred successful 2025, and continued businesslike gross procreation crossed each markets.
It reported a year-end 2025 currency equilibrium of $303 million, reflecting a maturation of $16 cardinal compared to $287 cardinal successful Q3 2025. The institution did not study immoderate debt, and expects its fiscal Q4 2025 nett gross to beryllium successful the scope of $48 to $53 million. Fiscal twelvemonth 2025 nett gross is expected to beryllium successful the $212 to $217 cardinal range.
Amarin Corporation plc (NASDAQ:AMRN) is simply a pharmaceutical institution progressive successful the improvement and commercialization of therapeutics targeting cardiovascular health. The company’s absorption is connected processing and commercializing Vascepa capsules.
While we admit the imaginable of AMRN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

2 days ago
1






English (CA) ·
English (US) ·
Spanish (MX) ·